Grzegorski T,
Losy J . Cognitive impairment in multiple sclerosis - a review of current knowledge and recent research.
Rev Neurosci. 2017; 27; 28(8):845-860. doi: 10.1515/revneuro-2017-0011.
Rocca MA, Amato MP, De Stefano N, et al. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol. 2015; 14(3):302–17.
Sumowski JF, Benedict R, Enzinger C, et al. Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology. 2018; 90(6):278–288. doi:10.1212/WNL.0000000000004977
Mehri A, Ghorbani A, Darzi A, Jalaie S, Ashayeri H. Comparing the production of complex sentences in Persian patients with post-stroke aphasia and non-damaged people with normal speaking. Iran J Neurol. 2016; 15(1):28–33.
Migliore S, Ghazaryan A, Simonelli I, et al. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability. Behav Neurol. 2017; 2017:7404289. doi:10.1155/2017/7404289
Lacy M, Hauser M, Pliskin N, Assuras S, Valentine MO, Reder A. The effects of long-term interferon-beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study. Mult Scler 2013; 19:1765–72.10.1177/1352458513485981
Rouleau I, Dagenais E, Tremblay A, Demers M, Roger E, Jobin C, et al. Prospective memory impairment in multiple sclerosis: A review.
Clin Neuropsychol. 2018;32(5):922-936. doi: 10.1080/13854046.2017.1361473.
Shafiee-Kandjani AR, Amiri Sh, Mousavi Z, Hashemilar M
, Safikhanlou S
, Abdi S
, Khalili M. cognitive function in hospitalized Patients with Multiple Sclerosis: A case-CONTROL STUDY. Archives of Neuroscience 2019;
6 (3); e89632
Lezak MD, Howieson DB, Bigler ED, Tranel D. Neuropsychological Assessment. 5th Ed. New York: Oxford University Press; 2012. pp. 290-303
Johnen A, Landmeyer NC, Burkner PC, Wiendl H, Meuth SG, Holling H. Distinct cognitive impairments in different disease courses of multiple sclerosis-A systematic review and meta-analysis.
Neurosci Biobehav Rev. 2017;83:568-78. doi:
10.1016/j.neubiorev .
Ntoskou K, Messinis L, Nasios G, et al. Cognitive and Language Deficits in Multiple Sclerosis: Comparison of Relapsing Remitting and Secondary Progressive Subtypes. Open Neurol J. 2018; 12:19–30. doi:10.2174/1874205X01812010019
Messinis L, Kosmidis MH, Vlahou C, Malegiannaki A, Gatzounis G, Dimisianos N, Karra A, Gourzis P. Papathanasopoulos. Phonological fluency strategy of switching differentiates Relapsing Remitting and Secondary Progressive Multiple Sclerosis Patients. ISRN Neurol. 2013 doi: 10.1155/2013/451429.
Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302. doi:10.1002/ana.22366
Nilipour R, Pour Shahbaz A, Ghoreishi Z S, Yousefi A. Reliability and Validity of Persian Aphasia Battery Test. Salmand: Iranian Journal of Ageing. 2016; 10 (4):182-191.
Kertesz A. Aphasia and Associated Disorders: Taxonomy, Localization, and Recovery. New York: Grune & Stratton; 1979.
Kertesz A. Western Aphasia Battery- Revised (WAB-R): Examiner’s Manual. PsychCorp. Harcort Assessment Incorporation, 2006.
Feenaughty L, Tjaden K, Benedict RH, Weinstock-Guttman B. Speech and pause characteristics in multiple sclerosis: a preliminary study of speakers with high and low neuropsychological test performance. Clin Linguist Phon. 2013;27(2):134–151. doi:10.3109/02699206.2012.751624
Rodgers JD, Tjaden K, Feenaughty L, Weinstock-Guttman B, Benedict RH. Influence of cognitive function on speech and articulation rate in multiple sclerosis. J Int Neuropsychol Soc. 2013;19(2):173–180. doi:10.1017/S1355617712001166
Kambanaros M, Messinis L, Nasios G, Nousia A, Papathanasopoulos P. Verb noun dissociations in relapsing remitting multiple sclerosis: Verb effects of semantic complexity and phonological relatedness. Aphasiology. 2017; 31:49–66. doi: 10.1080/02687038.2016.1154498.
Messinis L, Kosmidis MH, Lyros E, Papathanasopoulos P. Assessment and rehabilitation of cognitive impairment in multiple sclerosis. International Review of Psychiatry. 2010; 22:22-34
Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, Petersen RC. Classifying neurocognitive disorders: The DSM-5 approach. Nat. Rev. Neurol. 2014; 10:634–642. doi: 10.1038/nrneurol.2014.181.
Prakash RS, Snook EM, Lewis JM, Motl RW, Kramer AF. Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis. Mult Scler. 2008;14(9):1250–1261. doi:10.1177/1352458508095004
Friedova L,
Rusz J,
Motyl J,
Srpova B,
Vodehnalova K,
Andelova M,
Novotna K,
Novotny M,
Ruzickova H,
Tykalova T,
Kubala Havrdova E,
Horakova D,
Uher T. Slowed articulation rate is associated with information processing speed decline in multiple sclerosis: A pilot study.
J Clin Neurosci. 2019; 65:28-33. doi: 10.1016/j.jocn.2019.04.018.
Dehnavi S, Hashemi S, Zadeh-Mohammadi A. The effectiveness of psychodrama on reducing depression among multiple sclerosis patients. International Journal of Behavioral Sciences, 2016; 9(4): 32-35.
Nazarboland N, Tehranizadeh M, Mozaffarinejad F. Effectiveness of Cognitive Behavioral Therapy for Multiple Sclerosis (MS) Fatigue. International Journal of Behavioral Sciences, 2017; 10(4): 19-24.